Latest Insider Transactions at Azenta, Inc. (AZTA)
This section provides a real-time view of insider transactions for Azenta, Inc. (AZTA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Azenta, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Azenta, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 05
2024
|
Lawrence Y. Lin EVP, CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
28,813
+28.93%
|
$1,296,585
$45.0 P/Share
|
|
Dec 04
2024
|
David Dong Wang SVP & GM, SMS |
SELL
Sale (or disposition) back to the issuer
|
Direct |
140
-0.58%
|
$6,440
$46.65 P/Share
|
|
Nov 19
2024
|
Herman Cueto EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
712
-2.89%
|
$28,480
$40.07 P/Share
|
|
Nov 19
2024
|
Jason Joseph SVP, General Counsel, Secy. |
SELL
Open market or private sale
|
Direct |
1,139
-1.0%
|
$45,560
$40.07 P/Share
|
|
Nov 19
2024
|
David Dong Wang SVP & GM, SMS |
SELL
Open market or private sale
|
Direct |
348
-1.42%
|
$13,920
$40.07 P/Share
|
|
Nov 19
2024
|
Ginger Zhou SVP and General Manager, Genom |
SELL
Open market or private sale
|
Direct |
491
-1.75%
|
$19,640
$40.07 P/Share
|
|
Nov 19
2024
|
Violetta Hughes VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
163
-1.62%
|
$6,520
$40.07 P/Share
|
|
Nov 19
2024
|
Olga Pirogova SVP and CHRO |
SELL
Open market or private sale
|
Direct |
548
-2.75%
|
$21,920
$40.07 P/Share
|
|
Nov 19
2024
|
John Marotta President and CEO |
BUY
Open market or private purchase
|
Direct |
1,250
+1.22%
|
$50,000
$40.67 P/Share
|
|
Nov 19
2024
|
Martin D Madaus |
BUY
Open market or private purchase
|
Direct |
4,940
+40.02%
|
$197,600
$40.77 P/Share
|
|
Nov 18
2024
|
Didier Hirsch |
BUY
Open market or private purchase
|
Direct |
1,000
+22.4%
|
$39,000
$39.5 P/Share
|
|
Nov 18
2024
|
William L Cornog |
BUY
Open market or private purchase
|
Indirect |
12,500
+45.86%
|
$487,500
$39.6 P/Share
|
|
Nov 18
2024
|
John Marotta President and CEO |
BUY
Open market or private purchase
|
Direct |
12,716
+11.32%
|
$495,924
$39.48 P/Share
|
|
Nov 15
2024
|
Ginger Zhou SVP and General Manager, Genom |
BUY
Grant, award, or other acquisition
|
Direct |
8,651
+23.61%
|
$354,691
$41.51 P/Share
|
|
Nov 15
2024
|
David Dong Wang SVP & GM, SMS |
BUY
Grant, award, or other acquisition
|
Direct |
8,651
+26.13%
|
$354,691
$41.51 P/Share
|
|
Nov 15
2024
|
Violetta Hughes VP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,921
+40.7%
|
$283,761
$41.51 P/Share
|
|
Nov 15
2024
|
Jason Joseph SVP, General Counsel, Secy. |
BUY
Grant, award, or other acquisition
|
Direct |
13,841
+10.85%
|
$567,481
$41.51 P/Share
|
|
Nov 15
2024
|
Olga Pirogova SVP and CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
10,381
+34.26%
|
$425,621
$41.51 P/Share
|
|
Nov 15
2024
|
John Marotta President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
83,622
+49.04%
|
$3,428,502
$41.51 P/Share
|
|
Nov 06
2024
|
Alan J Malus |
BUY
Sale (or disposition) back to the issuer
|
Direct |
995
+50.0%
|
$45,770
$46.52 P/Share
|
|
Nov 06
2024
|
William L Cornog |
SELL
Sale (or disposition) back to the issuer
|
Direct |
995
-30.62%
|
$45,770
$46.52 P/Share
|
|
Nov 06
2024
|
Quentin Koffey Director |
BUY
Grant, award, or other acquisition
|
Direct |
995
+50.0%
|
-
|
|
Oct 17
2024
|
Herman Cueto EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,595
-6.09%
|
$68,585
$43.68 P/Share
|
|
Sep 09
2024
|
John Marotta President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
3,273
+50.0%
|
$150,558
$46.15 P/Share
|
|
Aug 09
2024
|
Ginger Zhou SVP and General Manager, Genom |
BUY
Grant, award, or other acquisition
|
Direct |
6,333
+24.67%
|
$348,315
$55.27 P/Share
|
|
Aug 09
2024
|
Jason Joseph SVP, General Counsel, Secy. |
BUY
Grant, award, or other acquisition
|
Direct |
10,856
+9.81%
|
$597,080
$55.27 P/Share
|
|
Aug 09
2024
|
Olga Pirogova SVP and CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
6,333
+39.9%
|
$348,315
$55.27 P/Share
|
|
Aug 09
2024
|
David Dong Wang SVP & GM, SMS |
BUY
Grant, award, or other acquisition
|
Direct |
6,333
+28.6%
|
$348,315
$55.27 P/Share
|
|
Aug 09
2024
|
Herman Cueto EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,309
+30.15%
|
$621,995
$55.27 P/Share
|
|
Aug 01
2024
|
Jason Joseph SVP, General Counsel, Secy. |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,000
-1.11%
|
$62,000
$62.05 P/Share
|
|
Jul 25
2024
|
Jason Joseph SVP, General Counsel, Secy. |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,000
-3.23%
|
$180,000
$60.0 P/Share
|
|
May 20
2024
|
Violetta Hughes VP, Chief Accounting Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
584
-15.59%
|
$29,784
$51.36 P/Share
|
|
Apr 01
2024
|
Jason Joseph SVP, General Counsel, Secy. |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,000
-1.06%
|
$60,000
$60.15 P/Share
|
|
Mar 08
2024
|
Jason Joseph SVP, General Counsel, Secy. |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,000
-4.08%
|
$268,000
$67.5 P/Share
|
|
Mar 07
2024
|
Jason Joseph SVP, General Counsel, Secy. |
SELL
Sale (or disposition) back to the issuer
|
Direct |
9,000
-2.88%
|
$585,000
$65.14 P/Share
|
|
Feb 12
2024
|
Frank Casal |
BUY
Grant, award, or other acquisition
|
Direct |
3,603
+27.73%
|
$234,195
$65.93 P/Share
|
|
Feb 12
2024
|
Tina Susan Nova |
SELL
Grant, award, or other acquisition
|
Direct |
2,465
-28.88%
|
$160,225
$65.93 P/Share
|
|
Feb 12
2024
|
Didier Hirsch |
BUY
Grant, award, or other acquisition
|
Direct |
2,465
+50.0%
|
$160,225
$65.93 P/Share
|
|
Feb 12
2024
|
Edward Peter Bousa |
SELL
Grant, award, or other acquisition
|
Direct |
2,465
-50.0%
|
$160,225
$65.93 P/Share
|
|
Feb 12
2024
|
Erica Mc Laughlin |
BUY
Grant, award, or other acquisition
|
Direct |
2,465
+16.13%
|
$160,225
$65.93 P/Share
|
|
Feb 12
2024
|
Martin D Madaus |
BUY
Grant, award, or other acquisition
|
Direct |
2,465
+50.0%
|
$160,225
$65.93 P/Share
|
|
Feb 12
2024
|
Michael Rosenblatt |
BUY
Grant, award, or other acquisition
|
Direct |
2,465
+15.9%
|
$160,225
$65.93 P/Share
|
|
Feb 12
2024
|
Robyn C Davis |
BUY
Grant, award, or other acquisition
|
Direct |
2,465
+7.69%
|
$160,225
$65.93 P/Share
|
|
Feb 01
2024
|
Robin Vacha SVP, GM Life Science Products |
BUY
Grant, award, or other acquisition
|
Direct |
324
+1.03%
|
$12,636
$39.41 P/Share
|
|
Feb 01
2024
|
Ginger Zhou SVP and General Manager, Genom |
BUY
Grant, award, or other acquisition
|
Direct |
448
+3.35%
|
$17,472
$39.41 P/Share
|
|
Jan 31
2024
|
Robin Vacha SVP, GM Life Science Products |
BUY
Grant, award, or other acquisition
|
Direct |
151
+0.48%
|
$8,003
$53.01 P/Share
|
|
Jan 31
2024
|
Ginger Zhou SVP and General Manager, Genom |
BUY
Grant, award, or other acquisition
|
Direct |
64
+0.49%
|
$3,392
$53.01 P/Share
|
|
Jan 31
2024
|
Violetta Hughes VP, Chief Accounting Officer |
SELL
Grant, award, or other acquisition
|
Direct |
311
-7.67%
|
$20,215
$65.2 P/Share
|
|
Dec 05
2023
|
Robin Vacha SVP, GM Life Science Products |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,175
-16.71%
|
$289,800
$56.6 P/Share
|
|
Dec 01
2023
|
David Dong Wang SVP & GM, SMS |
SELL
Sale (or disposition) back to the issuer
|
Direct |
138
-1.44%
|
$7,866
$57.96 P/Share
|